BiotechTube
Accure Therapeutics

Accure Therapeutics

Barcelona, Spain· Est.
accure.health
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Accure Therapeutics is a private, pre-revenue biotech focused on high-need CNS diseases. The company leverages a target-driven approach based on recent advances in neurobiology and neurodegeneration. Its strategy involves maturing early-stage programs to a validation point attractive for partnership or acquisition by larger pharmaceutical companies, supported by a seasoned executive team with deep CNS and biotech experience.

Central Nervous System (CNS)

Technology Platform

Target-driven small molecule discovery based on advances in neurobiology, neurodegeneration, and neuroinflammation, focusing on genetic, molecular, cellular, and systemic disease pathogenesis.

Funding History

1
Total raised:$10M
Series A$10M

Opportunities

The massive, underserved CNS market offers blockbuster potential for disease-modifying therapies.
Non-dilutive grant funding from prestigious organizations validates their science and extends runway.
A partnership-focused business model can provide significant upfront and milestone payments without the need for large commercial infrastructure.

Risk Factors

CNS drug development carries an extremely high failure rate due to biological complexity and translational challenges.
As a pre-revenue company, it faces significant funding risk and depends on raising capital to reach milestones.
Intense competition from larger, well-funded entities in the neurology space poses a threat.

Competitive Landscape

Accure operates in the highly competitive CNS therapeutic arena, competing against large pharmaceutical companies (e.g., Roche, Biogen, AbbVie) and numerous biotechs. Differentiation relies on novel mechanisms and efficient translation of preclinical science. Its small size and focus may allow for agility but limit resources compared to deep-pocketed rivals.

More companies in Small Molecule Drugs →More companies in Spain →